A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013. Comparison with a French strain that was pertussis toxin–deficient, pertactin wild-type showed that the strains carry the same 28-kb deletion in similar genomes
Whooping cough, caused by Bordetella pertussis, has resurged and presents a global health burden wor...
Despite high vaccination coverage, Bordetella pertussis the causative agent of whooping cough is sti...
SummaryObjectiveTo detect and characterize pertactin-negative Bordetella pertussis in Canada, especi...
A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin,...
Many countries have reported antigenic divergence among circulating Bordetella pertussis strains, ma...
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these...
AbstractSurprisingly, most Bordetella parapertussis isolates collected in France since 2007 do not e...
Evolution of Bordetella pertussis is driven by natural and vaccine pressures. Isolates circulating i...
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where ac...
This study examined the evolving nature of Bordetella pertussis in Ontario, Canada, by characterizin...
The adhesin pertactin (Prn) is one of the major virulence factors of Bordetella pertussis, the etiol...
Respiratory infections caused by Bordetella pertussis are reemerging despite high pertussis vaccinat...
Objective: To detect and characterize pertactin-negative Bordetella pertussis in Canada, especially ...
Despite vaccination, cyclical peaks of Bordetella pertussis incidence rates are still observed in Ca...
<div><p>The adhesin pertactin (Prn) is one of the major virulence factors of <em>Bordetella pertussi...
Whooping cough, caused by Bordetella pertussis, has resurged and presents a global health burden wor...
Despite high vaccination coverage, Bordetella pertussis the causative agent of whooping cough is sti...
SummaryObjectiveTo detect and characterize pertactin-negative Bordetella pertussis in Canada, especi...
A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin,...
Many countries have reported antigenic divergence among circulating Bordetella pertussis strains, ma...
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these...
AbstractSurprisingly, most Bordetella parapertussis isolates collected in France since 2007 do not e...
Evolution of Bordetella pertussis is driven by natural and vaccine pressures. Isolates circulating i...
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where ac...
This study examined the evolving nature of Bordetella pertussis in Ontario, Canada, by characterizin...
The adhesin pertactin (Prn) is one of the major virulence factors of Bordetella pertussis, the etiol...
Respiratory infections caused by Bordetella pertussis are reemerging despite high pertussis vaccinat...
Objective: To detect and characterize pertactin-negative Bordetella pertussis in Canada, especially ...
Despite vaccination, cyclical peaks of Bordetella pertussis incidence rates are still observed in Ca...
<div><p>The adhesin pertactin (Prn) is one of the major virulence factors of <em>Bordetella pertussi...
Whooping cough, caused by Bordetella pertussis, has resurged and presents a global health burden wor...
Despite high vaccination coverage, Bordetella pertussis the causative agent of whooping cough is sti...
SummaryObjectiveTo detect and characterize pertactin-negative Bordetella pertussis in Canada, especi...